These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Oehmig A, Cortés ML, Perry KF, Sena-Esteves M, Fraefel C, Breakefield XO. Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718 [Abstract] [Full Text] [Related]
8. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo. Wagstaff MJ, Lilley CE, Smith J, Robinson MJ, Coffin RS, Latchman DS. Gene Ther; 1998 Nov; 5(11):1566-70. PubMed ID: 9930311 [Abstract] [Full Text] [Related]
17. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Grant KG, Krisky DM, Ataai MM, Glorioso JC. Biotechnol Bioeng; 2009 Mar 01; 102(4):1087-97. PubMed ID: 18828174 [Abstract] [Full Text] [Related]
18. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Logvinoff C, Epstein AL. Virology; 2000 Feb 01; 267(1):102-10. PubMed ID: 10648187 [Abstract] [Full Text] [Related]
19. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS. McMenamin MM, Byrnes AP, Pike FG, Charlton HM, Coffin RS, Latchman DS, Wood MJ. Gene Ther; 1998 May 01; 5(5):594-604. PubMed ID: 9797863 [Abstract] [Full Text] [Related]
20. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo. Perez MC, Hunt SP, Coffin RS, Palmer JA. Gene Ther; 2004 Jul 01; 11(13):1023-32. PubMed ID: 15164091 [Abstract] [Full Text] [Related] Page: [Next] [New Search]